University of Strathclyde : Funding for AI technology used to calculate pre-eclampsia risk.
ENPNewswire-November 2, 2021--University of Strathclyde : Funding for AI technology used to calculate pre-eclampsia risk
(C)2021 ENPublishing - http://www.enpublishing.co.uk
Release date- 01112021 - A project proposal to develop new artificial intelligence (AI) technology to calculate women's risk of pre-eclampsia has been successful in the latest round of the UK Government's Artificial Intelligence in Health and Care Award.
King's College London, in partnership with the University of Strathclyde, has received almost GBP150,000 share of the funding over one year. Approximately GBP110,000 will fund innovative AI research at Strathclyde with the remainder used to support app development activities and outreach.
The researchers aim to develop, with industry partners, an app for determining individual women's risk of pre-eclampsia, and its potential severity, including post-birth complications.
They plan to combine two existing forms of a calculating tool known as PIERS (Pre-eclampsia Integrated Estimate of Risk Score), into an integrated system which is favourable to women, their midwives and doctors, and engineers.
Project Principal Investigator, Professor Peter von Dadelszen, Professor of Global Women's Health, King's College London, said: 'Developing, validating, and implementing the PIERS models has been a 20- year journey to date. During that time, our thinking about approaches, such as developing distinct models for well-resourced and resource-constrained settings, and the methods used to develop and test models has evolved.
'This award provides the opportunity provide individual pregnant women with high blood pressure, their families, and their care providers accurate information about their risks so that optimal shared decisions can be made about place of care and timing of birth. This matters because pre-eclampsia carries increased risks of maternal death, stillbirth, and newborn death, as well as 'near miss' events when deaths are narrowly avoided.
'This is true whether a woman lives in London or Lusaka, Glasgow or Garissa - it is a matter of distributed, equitable, and excellent care'.
Dr Kimberley Kavanagh, a Senior Lecturer in Strathclyde's Department of Mathematics and Statistics, is a partner in the project. She said: 'Pre-eclampsia is the most dangerous form of high blood pressure in pregnancy. It is responsible for the deaths of more than 70,000 women and 500,000 babies every year worldwide and costs the NHS alone GBP300...
To continue reading
Request your trial